• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Studies on the correlation between titer of antibodies against different function regions of hepatitis C virus and HCV RNA of chronic patients].

作者信息

Zhang He-qiu, Wang Guo-hua, Chen Kun, Xiu Bing-shui, Song Xiao-guo, Liu He-zhong, Ling Shi-gan

机构信息

Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Bejing 100850, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2003 Dec;11(12):754-5.

PMID:14697143
Abstract

OBJECTIVE

To detect humoral immune response against different function regions of hepatitis C virus (HCV) in chronic patients, and further to investigate the correlativity between anti-HCV antibody titers and HCV RNA concentration.

METHODS

Using recombinant dominate epitope antigens, e.g. HCV Core, NS3, NS4, NS5 and chimeric HVR1, a set of ELISA test reagents was formulated. Then, titers of antibodies against HCV different regions and the RNA concentration of HCV in chronic patient sera were detected by ELISA and quantitative RT-PCR technique, respectively.

RESULTS

Great differences have been noted in antibody titers and positive rate of different HCV function regions in chronic patients. Antibodies against HCV Core and HVR1 have the highest positive rate, then NS3, NS4, and NS5 in sequence.

CONCLUSION

The titer of antibodies against different regions of HCV in chronic patients has good correlation with HCV RNA concentration.

摘要

相似文献

1
[Studies on the correlation between titer of antibodies against different function regions of hepatitis C virus and HCV RNA of chronic patients].
Zhonghua Gan Zang Bing Za Zhi. 2003 Dec;11(12):754-5.
2
Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.慢性丙型肝炎患者经干扰素治疗根除丙型肝炎病毒(HCV)感染后HCV抗体状态的变化。
Clin Infect Dis. 2005 Mar 15;40(6):e49-54. doi: 10.1086/428128. Epub 2005 Feb 18.
3
Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.血清转换的注射吸毒者对丙型肝炎病毒结构蛋白(核心蛋白)和非结构蛋白(NS3、NS4和NS5)的定量抗体反应:表位变异的影响及其与血液中丙型肝炎病毒RNA检测的关系
Hepatology. 1999 Apr;29(4):1288-98. doi: 10.1002/hep.510290442.
4
Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.慢性乙型肝炎病毒-丙型肝炎病毒合并感染中的低水平丙型肝炎病毒血症及对NS4的体液免疫反应
Scand J Gastroenterol. 2004 Aug;39(8):778-82. doi: 10.1080/00365520410006332.
5
Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.1b型慢性丙型肝炎治疗期间丙型肝炎病毒抗体谱的序贯变化:对E2/NS1的治疗前抗体反应与持续应答相关。
Infection. 2004 Jun;32(3):153-6. doi: 10.1007/s15010-004-3133-x.
6
Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.透析患者和慢性肝病患者中的丙型肝炎病毒感染:病毒血症依赖性抗E2抗体反应。
J Med Virol. 2004 Aug;73(4):529-35. doi: 10.1002/jmv.20122.
7
[Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].[慢性丙型肝炎患者的血清自身抗体及其在丙型肝炎病毒感染中的意义]
Zhonghua Yi Xue Za Zhi. 2006 Feb 14;86(6):390-3.
8
Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.接受慢性丙型肝炎治疗且获得持续应答患者血清及肝脏病毒标志物的长期演变
J Viral Hepat. 2006 Jan;13(1):28-33. doi: 10.1111/j.1365-2893.2005.00650.x.
9
[Detection of HCV antigen in the serum by immunodotting].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 May;22(3):336-8.
10
[Evaluation of specific humoral response to hepatitis C core antigen in children].
Przegl Lek. 2003;60(12):802-5.